In vitro diagnostics specialists today have to design systems capable of carrying out increasingly complex tests while making the results easier to interpret. HORIBA Medical has risen to the challenge by considerably intensifying its research efforts. The company aims to invest over 10% of its sales in R&D in the medium term.
Many new concepts, that are unique, have been introduced in the field of in vitro diagnostics, including the most compact system on the market (Micros designed by HORIBA Medical).
Over 40 “key” patent families have been lodged worldwide, covering all the technologies included in our testing systems.

Key indicators

  • Over 1,100 employees
  • 4 production centers (Japan, China, France, Brazil)
  • 2 R&D centers (Japan, France)
  • Around 100 distributors
  • 13 local/direct operations
  • Around 30,000 laboratories supplied worldwide

17 Jan 2019 - 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine

Read more

MEDLAB 2019_HORIBA Medical_come and visit us

17 Jan 2019 - Come and visit us at HORIBA Medical booth #75.D10! MEDLAB is a must-attend annual event for the...

Read more

HELO fully automated haematology platform

3 Oct 2018 - New HELO fully automated high throughput system at Torbay reduces time taken for routine...

Read more